Juva | Jotup

Cervos Medical Announces Sanjay Batra, PhD as Chief Advisor - Cervos Aesthetics

Retrieved on:

Wednesday, January 17, 2024

Organization, Partnership, Regenerative medicine, Pleasure, Juva, Johnson & Johnson, Pharmaceutical industry

Key Points:

, Jan. 17, 2024 /PRNewswire/ -- Cervos Medical, an autologous biologics company, has announced the appointment of Dr. Sanjay Batra as "Chief Advisor – Cervos Aesthetics."
The company views this partnership as marking a significant step in targeting the regenerative aesthetic market through the launch of the Cervos Juva PRP line.
His appointment as Chief Advisor is not just a win for our company but a leap forward in the field of regenerative aesthetics."
Cervos Medical plans to launch the Juva PRP line in Q1 of 2024.

Juva Life Enrolls First Human Subject in Cannabis Registry Study

Retrieved on:

Tuesday, March 9, 2021

Entheogens, Euphoriants, Medicinal plants, Cannabis, Cannabis smoking, Juva, Plants, Branches of biology, Human behavior

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
The CSE does not accept responsibility for the adequacy or accuracy of this release.

Juva Life Commences Industrial Scale Cannabis Cultivation at Stockton Facility

Retrieved on:

Tuesday, February 23, 2021

Entheogens, Euphoriants, Medicinal plants, Cannabis, Cannabis smoking, Juva, Plants, Branches of biology, Pharmacognosy

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
The CSE does not accept responsibility for the adequacy or accuracy of this release.

Juva Life Advances Intellectual Property Protection Program and Advises on DTC Eligibility

Retrieved on:

Wednesday, January 27, 2021

Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Cannabis, Cannabis smoking, Juva, Plants, Branches of biology

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
The CSE does not accept responsibility for the adequacy or accuracy of this release.

Juva Life Initiates Clinical Registry as First Step in Building Evidence-Based Cannabis Technology Platform

Retrieved on:

Thursday, January 21, 2021

Branches of biology, Herbalism, Medicinal plants, Health sciences, Biology, Antiemetics, Antioxidants, Medical cannabis, Cannabis, Juva, DECIPHER

Key Points:

This is the first step towards building an integrated technology platform addressing serious and unmet medical needs.
Juva has designed a novel technology platform spanning natural products pharmacology, clinical science, and digital learning.
On August 25, 2020, the Juva Life-sponsored Informed Patient Cannabis Therapy Registry (The IMPACT Registry) was approved by the WCG IRB .
Juva is one of the very first companies to develop a cannabis platform to decipher the putative clinical effects of cannabis.

Juva Life Receives California Cultivation License for Stockton Facility

Retrieved on:

Tuesday, January 19, 2021

Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Cannabis, Cannabis smoking, Juva, Plants, Branches of biology

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
The CSE does not accept responsibility for the adequacy or accuracy of this release.

Juva Life Unifies and Accelerates Brand Marketing Plans

Retrieved on:

Thursday, January 14, 2021

Cannabis, Cannabis smoking, Entheogens, Euphoriants, Juva, Branches of biology

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing.

Juva Life Brings Bold Outlook for the New Year

Retrieved on:

Monday, January 4, 2021

Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Cannabis, Cannabis smoking, Juva, Plants, Branches of biology

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
The CSE does not accept responsibility for the adequacy or accuracy of this release.

Juva Life Transforming Ex-Cancer Research Facility into Flagship Operation

Retrieved on:

Tuesday, December 22, 2020

Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Cannabis, Cannabis smoking, Juva, Plants, Branches of biology

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
The CSE does not accept responsibility for the adequacy or accuracy of this release.

Juva Life Features Redwood City Operational Update

Retrieved on:

Wednesday, December 16, 2020

Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Cannabis, Cannabis smoking, Juva, Plants, Branches of biology

Key Points:

Juva Lifeis working to bring the cannabis market face to face with the sectors next generation investment grade business model.
From in-house research, cultivation, manufacturing, retail, and delivery services, Juva employs state of the art tools in discovery, development, and data science to identify new molecular profiles for major unmet medical needs.
Our initial focus is on cannabis, where we are deploying our platform to target consumer and pharma applications.
The CSE does not accept responsibility for the adequacy or accuracy of this release.